Evidence map›Paper›PMID 14628075›Full record

ArticleLeukemia2004

Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation.

Q Zhao, J Tao, Q Zhu, P-M Jia, A-X Dou, X Li, F Cheng, S Waxman, G-Q Chen, S-J Chen and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Q ZhaoState Key Lab for Human Genome Research (SKLHGR), Shanghai Institute of Hematology, Ruijin Hospital, Samuel Waxman Cancer Research Foundation Laboratory of Shanghai Second Medical University (SSMU), Shanghai, China.
J Tao
Q Zhu
P-M Jia
A-X Dou
X Li
F Cheng
S Waxman
G-Q Chen
S-J Chen
M Lanotte
Z Chen
J-H Tong
Ruijin Hospital · CNShanghai Institute of Hematology · CNHôpital Saint-Louis · FRMount Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The second messenger cyclic adenosine monophosphate (cAMP) plays an important role in cell proliferation, differentiation and apoptosis. In the present work, we evaluated the cAMP signaling in acute promyelocytic leukemia (APL) cells in the context of differentiation induced by all-trans retinoic acid (ATRA). There was a marked increase in the intracellular cAMP level within a few minutes after treatment with ATRA in APL cell line NB4 and fresh APL cells, whereas no such phenomenon was observed in NB4-R1 cells that are resistant to ATRA-induced maturation. In addition, the basal level of intracellular cAMP was lower in NB4-R1 than in NB4 cells. Mechanistic study showed that this induction of cAMP was mediated through the activation of adenylate cyclase. Moreover, we found that cAMP-dependent protein kinase (PKA) activity was quickly upregulated in parallel in ATRA-treated NB4 cells, and the phosphorylation of RARalpha by PKA could increase its transactivation effect. Use of H-89, an inhibitor of PKA, could partially suppress the transcriptional expression of ATRA target genes and ATRA-induced differentiation of APL cells. Taken together, we suggested a crosstalk between ATRA-induced cytosolic pathway and nuclear pathway in APL cell differentiation.

Indexed as

Adenylyl CyclasesCell DifferentiationCell Line, TumorCyclic AMPCyclic AMP-Dependent Protein KinasesHumansLeukemia, Promyelocytic, AcutePhosphorylationReceptor Cross-TalkReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoic Acid Receptor alphaSecond Messenger SystemsTretinoinTumor Cells, CulturedUp-RegulationAdenylyl CyclasesCyclic AMPCyclic AMP-Dependent Protein KinasesRARA protein, humanReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoic Acid Receptor alphaTretinoin

Identifiers

PMID14628075
OpenAlexW2103962971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.